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Abstract
Transperineal prostate biopsy is a procedure that can be used to obtain histological samples from the prostate. 
To improve both the quality of the biopsy core samples and prostate cancer detection, we are currently performing 
a prospective, randomized trial comparing prostate biopsy samples obtained using an 18 G-needle to those obtained 
using a 16 G needle. The aim of this preliminary study was to evaluate pain and complication rates in both groups 
in order to assess whether performing a prostate biopsy with a larger calibre needle is a feasible procedure. One 
hundred and eighty-seven patients undergoing transperineal prostate biopsy were prospectively evaluated and 
divided into two groups. The first group (94 patients, Group A) received a transperineal prostate biopsy using 
a 16 G-needle and the second group (93 patients, Group B) underwent transperineal prostate biopsy with an 
18 G-needle.  Anaesthesia was obtained with a single perineal injection at the prostatic apex in all subjects.  A 
visual analogue scale (VAS) and facial expression scale (FES) were used to assess pain during multiple steps of the 
procedure in each group.  A detailed questionnaire was used to obtain information about drug use because it could 
potentially influence the pain and complications that patients experienced.  Two weeks after the procedure, early 
and late complications were evaluated.  Statistical analysis was carried out using non-parametric tests.  Prostate 
Specific Antigen (PSA) and drug use were similar at baseline between the two groups.  Pain during prostate biopsy, 
which was measured with both the VAS and FES instruments, did not differ significantly between the 18- and 
16 G-needle groups, and no significant differences were found in early or late complication rates between the groups. 
Transperineal prostate biopsy with a 16 G-needle is a feasible procedure in terms of pain and complication rates. 
Further studies with larger patient populations are required to assess whether or not this procedure can improve 
prostate cancer detection rates.
Asian Journal of Andrology (2009) 11: 678–682.  doi: 10.1038/aja.2009.43; published online 21 September 2009.
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1    Introduction
Since the beginning of the last century, transrectal 
ultrasound-guided needle biopsy of the prostate has been 
used to diagnose prostate cancer, and it is considered to 
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be an accurate method for obtaining prostatic tissue for 
histological evaluation [1, 2]
The transperineal biopsy approach has been 
developed in more recent years, and is considered to be 
an adequate alternative to the transrectal approach [3]. 
In fact, no significant differences were found in terms of 
cancer detection or complication rates between the two 
approaches in a recent prospective, randomized study 
by Hara et al. [4].  An 18-G needle is the most common 
needle calibre used to obtain prostatic tissue, although 
this convention is derived from the transrectal approach, 
which requires this needle size.  As reported in previous 
breast cancer trials, tissue harvested using smaller 
needles is frequently friable and tends to fragment more 
often than tissue harvested using larger ones [5].  The 
use of a larger calibre needle certainly increases the 
amount of tissue harvested during biopsy and could 
potentially improve histological sampling, thereby 
enhancing the accuracy of prostate cancer diagnosis. 
In a previous study, 14-G needles were compared with 
16-G needles in patients undergoing breast biopsies, 
and the results indicated that patients who underwent 
breast biopsy using the larger calibre needle did not 
experience significantly worse side effects than patients 
whose biopsy was performed using the smaller needle 
[5].  On the basis of these findings, we sought to 
examine whether or not the same findings would hold 
true in prostate biopsies.  Therefore, we are currently 
performing a prospective, randomized study comparing 
the use of 16-G versus 18-G needles in transperineal 
prostate biopsies.  We present our preliminary findings 
with the use of 16-G needles in transperineal prostate 
biopsies, and critically analyze data regarding pain and 
complication rates.
2    Materials and methods
Between November 2006 and September 2007, 187 
patients undergoing ultrasound-guided transperineal 
prostatic biopsy were enrolled in this study and 
randomly divided into two groups.  One group 
underwent biopsy using a 16-G needle (94 patients, 
Group A) and the other underwent biopsy using an 
18-G needle (93 patients, Group B).  Local anaesthesia 
was administered by means of a single transperineal 
injection of mepivacaine (4 mL) plus 1 mL bicarbonate 
at the prostatic apex, which was administered using a 
22-G needle.
The inclusion criteria for the study included the 
following characteristics: (1) prostate-specific antigen 
(PSA) > 2.5 ng mL-1; (2) increasing PSA velocity; (3) 
PSA free: total ratio > 16; and (4) a suspicious digital 
rectal examination.  Exclusion criteria were (1) previous 
prostatic biopsy; (2) age > 75 years; (3) presence of 
significant co-morbidities; and (4) biopsies performed 
by urologists not mentioned in this study.
All biopsies were performed by two skilled operators. 
A total of 12 samples (6 per side) were obtained from 
each biopsy.  An automatic Pro-mag 2.2 device (ProMag, 
MD Tech, Gainesville, USA) was used for all biopsies. 
Transrectal ultrasound was performed using a 7.5 MHz 
biplanar probe.  Each transrectal ultrasound that was 
performed included an assessment of prostatic diameter, 
the volume of the whole prostate, and the transition 
zone and capsular and seminal vesicle characteristics, 
as well as a morphological description of potential 
pathological features in the peripheral or transition 
zone.  Antibiotic prophylaxis was performed in all 
patients using oral fluoroquinolones.
Needle cores were placed in tissue cassettes between 
two sponges that had been previously treated with 
70% ethanol.  Each core sample was numbered, and 
identified by biopsy site and prostate lobe.  The core 
biopsies were distributed in pairs, and the tissue 
cassettes were then submitted to pathology in containers 
filled with 10% buffered formalin.
At the end of the procedure, the patients were 
administered two scales that analyzed the pain and 
discomfort domains.  The first one was the visual 
analogue scale (VAS), which is easy to understand 
and scores pain from 0 to 10 depending on pain 
intensity.  The second scale uses facial expressions 
to indicate pain intensity, and is graded from 0 to 10. 
Patients were asked to match the picture with his/her 
pain level.  Finally, each subject was asked to answer 
several questions about drug use during the preceding 
2 weeks (Did you take drugs that had anti-platelet 
activity, warfarin, dicumarolic agents, non-steroidal 
anti-inflammatory agents, steroids, or benzodiazepines 
during the past 2 weeks?).  All anti-coagulants were 
stopped at least 8 days before the procedure.  Patients 
whose anti-coagulant therapy could not be suspended 
had their regular anti-coagulant medication converted 
to low molecular weight heparin.
At 2 weeks after prostatic biopsy, the patients 
were interviewed and asked questions regarding pain 
persistence or the recurrence, and possible side effects 
(haematuria, urinary retention, fever, etc).
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All data were entered into a database and statistically 
analyzed using Statistical Package for Social Sciences, 
version 13.0 for Windows (SPSS Inc., Chicago, Ill).  A 
preliminary descriptive analysis of all the variables was 
performed.  Statistical analyses were carried out using 
the unpaired t-test, Mann–Whitney U-test, Wilcoxon 
test and χ 2-test.
3    Results
The mean age of patients in Group A was 66.7 ± 7.1 
years and the mean age of patients in Group B was 69.4 
± 8.7 years (P = 0.02).  PSA levels, diabetes rates and 
overall drug consumption rates were similar between 
the two groups (P = 0.055, 0.8 and 0.3, respectively). 
This last finding may be of interest with regard to 
complication rates, and may even influence patients’ 
feelings and subjective perception of pain.
Visual analogue scale pain scores are summarized 
in Table 1.  Pain was assessed at three separate time 
points: at the time of perineal anaesthesia, at the time 
of the biopsy procedure and at the 15-day follow-up 
appointment.  Pain, which was assessed by both the 
VAS score and the facial expression scale (FES), did not 
differ significantly between the two groups at any of the 
three time points (Table 1).  The overall complication 
rate (which included haematuria, mild vagal symptoms/
reaction, the need for more anaesthesia, acute urinary 
retention and fever) was 26.5% (26 points) in Group A 
and 24.4% (23 points) in Group B (P = 0.22).  In both 
groups, the most common complication was haematuria.
A total of 26 prostate cancers were detected in each 
group (P = 0.547).  In total, 15 cases of high-grade 
prostatic intraepithelial neoplasia (HGPIN) were found 
among patients in the 18-G needle group and 10 cases 
of HGPIN were identified among patients in the16-G 
needle group (P = 0.187).  A single case of atypical 
small acinar proliferation (ASAP) was detected in 
Group A, whereas four cases of ASAP were detected in 
Group B (P = 0.181).
4    Discussion
Transperineal prostatic biopsy is a technique that can 
be used to adequately sample prostatic tissue.  Although 
initially applied to patients who had previously 
undergone abdominoperineal resection, this approach 
has since been used more widely and has been found 
to have a significant cancer detection rate as well as 
acceptable morbidity.  Transperineal prostate biopsy 
requires the use of local anaesthesia, which it is often 
also used for transrectal prostate biopsies to reduce 
discomfort and pain [6].  Injection of a local anaesthetic 
agent at the prostate apex is a common anaesthetic 
technique used in the transperineal biopsy approach.  In 
fact, it seems to be easier to perform and less painful 
than the prostatic plexus block that is used during 
transrectal biopsies [7].
Patients’ pain and discomfort during prostatic 
biopsy are interesting topics in the modern literature. 
To evaluate pain perception, Soyupek et al. [8] recently 
invoked the modified tourniquet test as a predictor 
of pain during prostate biopsy.  Different anaesthetic 
strategies have also been evaluated.  Cam et al. [9] 
recently assessed the role of intraprostatic injections 
of a local anaesthetic agent during transrectal prostate 
biopsy and found that intraprostatic injections provide 
better pain control than periprostatic injections.
Raber et al. [10] compared the pain control obtained 
by a single periprostatic nerve block both alone and in 
combination with topical prilocaine-lidocaine cream. 
As predicted, adding a topical anaesthetic agent was 
found to be beneficial in preventing pain, a finding that 
was particularly evident in younger patients.
The devices used to perform a prostate biopsy, such 
as the needle, may also influence patients’ pain.  Novella 
and co-workers [11] used a coaxial transperineal needle 
during transperineal prostate biopsy to see whether it 
could reduce patients’ pain.  The authors found that 
the use of a coaxial transperineal needle decreased 
the overall invasiveness of the procedure.  The same 
Table 1.  Patients’ pain scores at different time points, as assessed by the visual analogue scale (VAS) and facial expression scale (FES).
  Group A (16 G) (N = 94) Group B (18 G) (N = 93) P-value
 Pain during anaesthesia (VAS) 4.02 4.09 0.5
 Pain during biopsy (VAS) 2.07 2.34 0.37
 Pain after 15 days (VAS) 0.06 0.07 0.91
 Pain during anaesthesia (FES) 4.02 4.19 0.37
 Pain during biopsy (FES) 2.03 2.1 0.7
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authors analyzed the length of the cores obtained 
from transperineal biopsy with regard to pathological 
features.  They concluded that the obtained core length 
was adequate and that the cores met the parameters 
of quality required by pathologists for the appropriate 
evaluation of the biopsy specimen [12].
To our knowledge, we report the first prospective 
and randomized trial evaluating the use of differing 
needle calibres in transperineal prostate biopsies.  The 
lack of previous studies on this topic may be because of 
the higher popularity of the transrectal approach, which 
limits researchers’ and clinicians’ experiences with 
the transperineal approach.  Transrectal biopsies are 
currently performed using a maximum needle calibre of 
18 G.  There have been no previous reports evaluating 
the use of larger calibre needles in transrectal prostate 
biopsies.
The effectiveness and safety of different needle 
sizes has been shown in breast cancer.  In one study, the 
use of an 18-G needle provided a 6.4-mm2 specimen, 
compared with the 9.6-mm2 (mean values) sample 
obtained using a 16-G needle[5].  As a result, the quality 
of the tissue samples obtained during biopsy was 
significantly superior when a 16-G needle was used. 
Manju et al. [13] confirmed those findings, stating that 
a larger specimen may lead to an improved diagnostic 
sensitivity and cancer detection.  In terms of prostate 
cancer, the only report concerning biopsy specimen 
size is the one from Iczkowski et al. [14], who found, 
in 2002, that needle core length on sextant biopsy may 
influence the cancer detection rate, especially at the 
apex.
Our study sought to take the first step in evaluating 
the feasibility of performing transperineal biopsies 
using a 16-G needle.  Using a prospective, randomized 
study design, we compared two groups with similar 
baseline characteristics with regard to PSA levels, 
incidence of diabetes and drug use.  Although age 
turned out to be significantly different between the 
groups, the mean value was older than 60 years in both 
groups.  This finding has clinical importance, as several 
authors have found that patients under 60 years of age 
experience more discomfort during prostate biopsy than 
older patients [15, 16].
The two groups (those that received their biopsy 
using a 16-G needle and those who received their biopsy 
using an 18-G needle) did not differ in terms of the pain 
they experienced associated with prostate biopsy, which 
was assessed in two different ways (the VAS and FES 
pain scales) to provide more significant and detailed 
outcomes.  Discomfort was assessed and recorded at the 
three separate steps that could be potentially distressing 
to patients, such as during anaesthesia, and during and 
15 days after biopsy.  Complication rates were not 
affected by needle calibre, even at the 15-day follow-up 
appointment.  Our data confirm that 16-G transperineal 
prostate biopsy can be easily and safely performed. 
Although pathological analysis of the prostate biopsy 
cores obtained during this study did not reveal any 
statistically significant differences in overall cancer, 
HGPIN or ASAP-detection rates, we are currently 
continuing our research on this topic.  There is a clear 
trend towards a significant improvement in diagnostic 
aptitude in patients who have undergone biopsy 
using a 16-G needle compared with those using an 
18-G needle (data not presented).  Despite the similar 
number of prostate cancers detected in both groups, the 
histological findings of uncertain malignant potential, 
such as ASAP, are encouraging, as those diagnoses 
seem to be more frequent in the 18-G needle group in 
which core quality and quantity is lower.
Therefore, although we have shown that this 
procedure is feasible and does not lead to increased side 
effects, further studies are required to better understand 
whether or not the use of a larger-calibre needle may 
potentially improve the detection rate of prostate 
cancers and reduce findings of ASAP and HGPIN, 
which represent serious concerns for both the urologist 
and the patient.
5    Conclusions
Pain assessment during prostatic biopsy is a popular 
topic in the recent literature.  The modified transperineal 
technique using a 16-G needle is a feasible procedure 
that is well tolerated by patients in terms of both pain 
and side effects.  The impact of a greater needle calibre 
on oncological outcomes remains to be determined. 
However, in addition to the increase in the number of 
biopsy cores obtained, we believe that this procedure 
may lead to a quantitative and qualitative improvement 
in histological sampling that may, in turn, potentially 
improve the diagnosis of prostate cancer.
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